IL10 and Sepsis: Impaired phagocytosis of alveolar macrophages in advanced sepsis further increases the severity of ARDS, and IFN-β treatment reverses the impairment of AM function induced by IL-10 and reduces the severity and mortality of ARDS in a dose-dependent manner25.